Related Experiment Videos
[Immunomodulating action of myelopeptides in severe closed experimental craniocerebral injury in rats]
Abstract:
An immunocorrective effect of myelopeptides (MP) isolated from pig bone marrow cell culture supernatant in the early posttraumatic period in rats with severe cranial injury has been assessed. MP administration prevented cellular devastation of thymus and bone marrow, as well as spleen hyperplasia. The most marked MP effect was observed within the first 24 h after its administration. MP affected the functional and migration properties of both the entire population of lymphoid cells and individual subpopulations. MP had a pronounced protective effect against Staph. aureus infection during cranial trauma. MP completely prevented the death of animals and reduced more than 3-fold Staph. aureus persistence in the organism of animals. Anti-stress and protective effects of MP open vast prospects for their therapeutic and preventive application in the clinical practice.
Insights
Myelopeptides (MP) from pig bone marrow protect against severe cranial injury in rats. MP administration improved immune cell function and prevented Staphylococcus aureus infection, showing therapeutic potential.
Area of Science:
- Immunology
- Traumatology
- Pharmacology
Background:
- Severe cranial injuries can lead to significant immune system dysfunction.
- Post-traumatic infections, such as Staphylococcus aureus, complicate recovery and increase mortality.
- Bone marrow-derived factors may possess immunomodulatory and protective properties.
Purpose of the Study:
- To assess the immunocorrective effects of myelopeptides (MP) in rats with severe cranial injury.
- To evaluate the protective impact of MP against Staphylococcus aureus infection following trauma.
- To investigate the influence of MP on immune cell populations and functions.
Main Methods:
- Isolation of myelopeptides (MP) from pig bone marrow cell culture supernatant.
- Administration of MP to rats in the early post-traumatic period after severe cranial injury.
- Assessment of thymus, bone marrow, and spleen cellularity and morphology.
- Evaluation of lymphoid cell functional and migration properties.
- Infection model using Staphylococcus aureus to assess MP's protective effect.
Main Results:
- MP administration prevented thymus and bone marrow cellular devastation and spleen hyperplasia.
- The most significant MP effects were observed within 24 hours of administration.
- MP modulated the functional and migration properties of both total lymphoid cells and subpopulations.
- MP demonstrated a pronounced protective effect against Staphylococcus aureus infection, preventing animal death and reducing bacterial persistence.
- MP exhibited anti-stress and protective effects.
Conclusions:
- Myelopeptides (MP) exert significant immunocorrective effects in the early post-traumatic period following severe cranial injury.
- MP protect against secondary Staphylococcus aureus infection and associated mortality.
- The findings suggest broad therapeutic and preventive applications for MP in clinical practice, particularly in trauma and infection management.